AMD
Expert imaging recommendations for geographic atrophy
A look at the latest report from the Classification of Atrophy Meeting Group.
How OCT is improving early characterization of GA lesions
A comparison of B-scan and en face imaging techniques for diagnosis of early macular atrophy.
CST changes and VA in nAMD: A review of the evidence
Post-hoc analyses and real-world studies demonstrate the link between central subfoveal thickness fluctuations and visual acuity in neovascular age-related macular degeneration.
Metformin’s potential impact on AMD prevention
Multiple observational studies have shown the potential of the antidiabetic drug in the management of age-related macular degeneration.
Reframing the discussion around geographic atrophy
Understanding the natural disease progression will help us talk to our patients about new and emerging treatments.
Understanding the risk of GA in nAMD
A look at research that sheds new light into the progression of geographic atrophy in neovascular age-related macular degeneration.
Update on mitochondrial stabilizers
Also from the Angiogenesis, Exudation, and Degeneration meeting, emerging treatments for nAMD and MacTel2, and a marker for anti-VEGF success in ROP.
Axitinib implant shows early potential
Interim results from Phase I trial of OTX-TKI, a bioresorbable hydrogel platform using a tyrosine kinase inhibitor.
AAO Report: New insights into ILM tears, trial readouts and more
Five abstracts on gene therapy and role of central subfield thickness in diabetic macular edema, vitreous hemorrhage and retinopathy of prematurity.
Treat and extend: An international view
Three experts from Canada, Switzerland and Israel provide insights into the nuances of adherence, treatment intervals and emerging therapies.
A closer look at emerging drug-delivery platforms
An update on Port Delivery System with ranibizumab, a large-molecule anti-VEGF candidate and subretinal gene therapy to treat neovascular AMD.
Retinal implant platforms moving from uveitis to AMD
Treatments show potential for various posterior-segment diseases based on their success treating noninfectious uveitis.
Using OCT to evaluate fluid in non-neovascular AMD
How optical coherence tomography, OCT angiography and fluorescein angiography can help direct diagnosis and treatment decisions.
Five emerging treatments show mixed results
Uncertainty about PVL for VMT and aflibercept for NPDR, some clarity on PDT, and early promise for stem cells and a bioresorbable implant.
How imaging is advancing management of dry AMD
Emerging modalities and deep learning are helping to expose an old foe in non-neovascular age-related macular degeneration: reticular pseudodrusen.
Imaging biomarkers and precision medicine
Advances in computational power, and machine learning and diagnostic systems are creating new opportunities for understanding disease mechanisms.
Where genetics, diet and drusen size intersect
A close look at research into how diet may reverse the effect of genetic susceptibility in drusen size progression in age-related macular degeneration.
Will biosimilars find their place in retina?
With patents expiring, an approval pending and legislation aimed at easing regulations, more biosimilars could be coming. But are retina specialists ready?
The complement pathway in geographic atrophy explained
Examining the role of complement factors in advanced disease.
The promise of targeting mitochondria in dry AMD
Mitochondrial therapies have shown the potential to improve visual function in patients with dry age-related macular degeneration.
Current Issue
Continuing Medical Education
Additional Publications
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Sponsored by Regeneron
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
Eyepoint Yutiq: A Discussion Among Experts on the Treatment of Uveitis Affecting the Posterior Segment
